ESC Professional Premium Access

A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant.

Topic: Infiltrative Myocardial Disease

Congress Session

About the speaker

Doctor Yousuf Razvi

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Family screening in dilated cardiomyopathy- qualifying screening and need for follow-up

Speaker: Doctor C. Vissing (Copenhagen, DK)

Thumbnail

Prognostic prediction of genotype versus phenotype in genetic cardiomyopathies

Speaker: Doctor A. Paldino (Trieste, IT)

Thumbnail

Mechano-energetic efficiency in patients with hypertrophic cardiomyopathy with and without sarcomeric mutations.

Speaker: Doctor F. Borrelli (Naples, IT)

Thumbnail

Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy

Speaker: Doctor C. Lee (New York, US)

Thumbnail

Different prognosis of ARVC patients between DSG2 and PKP2 variant carriers

Speaker: Doctor K. Sonoda (Osaka, JP)

Thumbnail

Access the full session

Genes and cardiomyopathies

Speakers: Doctor Y. Razvi, Doctor C. Vissing, Doctor A. Paldino, Doctor F. Borrelli, Doctor C. Lee...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk